20
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Nanovesicular Ultraflexible Invasomes and Invasomal Gel for Transdermal Delivery of Phytopharmaceuticals

ORCID Icon, ORCID Icon & ORCID Icon
Pages 737-740 | Received 07 Feb 2024, Accepted 13 Feb 2024, Published online: 29 Feb 2024
 

Tweetable abstract

Invasomes and invasomal gel are ultraflexible, soft vesicular, phospholipid based nanocarriers with deeper skin penetration ability for transdermal applications of drugs and phytopharmaceuticals.

Author contributions

D Mohapatra contributed to the conceptualization and writing of the original manuscript. AN Sahu and PC Acharya contributed to conceptualization, supervision, expert assistance, editing, drafting and revision functions.

Acknowledgments

The authors are extremely grateful to Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi for providing infrastructural facilities. AN Sahu is thankful to Council of Science and Technology, Uttar Pradesh (CST, UP) for providing funding (sanction order no: CST/D-1163) for developing carbon nanodots for oral cancer. PC Acharya is thankful to Department of Biotechnology-Scientific Infrastructure Access for Harnessing Academia University Research Joint Collaboration (DBT-SAHAJ) for providing funding (sanction order no: BT/INF/22/SP44789/2021) and establishment of Drug Metabolomics Laboratory at Tripura University. The financial assistance provided as a scholarship to D Mohapatra by the Ministry of Human Resource Development (MHRD), Government of India is greatly acknowledged.

Financial disclosure

The authors have no financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, stock ownership or options and expert testimony.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.